Development and Validation of the GLORI-COPD Score

NCT04027296 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 462

Last updated 2026-04-29

No results posted yet for this study

Summary

The objective of this study is to evaluate the diagnostic accuracy of the GLORI-COPD score in ambulatory care, to enable the screening of COPD patients at risk of complications, requiring early management

Conditions

  • Pulmonary Disease, Chronic Obstructive

Sponsors & Collaborators

  • Recherche Clinique Paris Descartes Necker Cochin Sainte Anne

    collaborator OTHER
  • Assistance Publique - Hôpitaux de Paris

    collaborator OTHER
  • University of Paris 5 - Rene Descartes

    lead OTHER

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2025-11-01
Completion
2025-11-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04027296 on ClinicalTrials.gov